Knoll Capital Management, LLC Vascular Biogenics Ltd. Transaction History

Knoll Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$1.1 - $1.32 $23,540 - $28,248	-21,400 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.16 - $1.53 $24,824 - $32,742	21,400 New	21,400 $28,000
Q4 2018 Feb 14, 2019	SELL	$0.6 - $1.72 $538,062 - $1.54 Million	-896,771 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$5.65 - $9.0 $204,337 - $325,494	36,166 Added 4.2%	896,771 $6.37 Million
Q3 2017 Nov 14, 2017	BUY	$4.15 - $7.2 $3.57 Million - $6.2 Million	860,605	860,605 $5.25 Million

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Knoll Capital Management, LLC with notifications on news.